A support programme for secondary prevention in patients with transient ischaemic attack and minor stroke (INSPiRE-TMS): an open-label, randomised controlled trial
The Lancet Neurology
Fecha de publicación: 7 November 2019
DOI: https://doi.org/10.1016/S1474-4422(19)30369-2
Autores: Michael Ahmadi, MD., Inga Laumeier, MD., Thomas Ihl, MD., Maureen Steinicke, MD., Caroline Ferse, MD., Prof Matthias Endres, MD
et al.
Background: Patients with recent stroke or transient ischaemic attack are at high risk for a further vascular event, possibly leading to permanent disability or death. Although evidence-based treatments for secondary prevention are available, many patients do not achieve recommended behavioural modifications and pharmaceutical prevention targets in the long-term. We aimed to investigate whether a support programme for enhanced secondary prevention can reduce the frequency of recurrent vascular events.
